M11.079
Hydroxyapatite deposition disease, unspecified ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite Deposition Disease (HADD) is a condition characterized by the buildup of calcium phosphate crystals, specifically hydroxyapatite, in the soft tissues around joints. When it affects the ankle and foot, it can cause pain, swelling, and limited movement. This condition is often diagnosed through imaging studies and may require various treatments to alleviate symptoms. The ICD-10 code M11.079 is used to classify cases of this disease when the specific joint area is not clearly specified. HADD is a type of calcific tendinitis, and understanding its causes, symptoms, diagnosis, and treatment options can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Degenerative changes in tendons and soft tissues Repetitive stress or injury to the ankle or foot Chronic inflammation or microtrauma Age-related metabolic changes Underlying metabolic or systemic conditions that affect calcium metabolism
Key Symptoms: Localized pain in the ankle or foot, often sudden and intense Swelling and tenderness around the affected area Restricted movement or stiffness in the joint Possible warmth and redness over the joint Pain that worsens with activity or pressure
Diagnostic & Treatment
Diagnosis Path: Diagnosing hydroxyapatite deposition disease typically involves a combination of clinical evaluation and imaging studies. X-rays are commonly used to identify calcified deposits in soft tissues around the joint. Ultrasound may also be helpful in detecting calcium deposits that are not visible on X-rays. In some cases, magnetic resonance imaging (MRI) can be utilized for detailed assessment of soft tissue involvement. Blood tests are generally not specific but may be performed to rule out other conditions related to calcium metabolism or systemic inflammation.
Treatment Protocols: Rest and activity modification to reduce stress on the affected joint Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation Application of ice packs to decrease swelling Physical therapy to improve joint mobility and strength In some cases, corticosteroid injections may be administered directly into the affected area Extracorporeal shock wave therapy (ESWT) has been used in certain cases to break down calcifications Surgical removal of calcium deposits may be considered if conservative treatments fail or if symptoms are severe
Clinical Advice & FAQs
Billing Guidance
Is M11.079 a billable ICD-10 code?
Yes, M11.079 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.079?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference